LAMI FEDERICO

Lami, F., Romerio, A., Valle-Gomez, L., Martin-Camara, O., Martin-Santamaria, S., Peri, F. (2026). Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives. JOURNAL OF MEDICINAL CHEMISTRY, 69(1), 72-86 [10.1021/acs.jmedchem.5c02252]. Dettaglio

Italia, A., Franco, A., Shaik, M., Romerio, A., Lami, F., Lovisa, S., et al. (2025). Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases. In Convegno Nazionale della Divisione di Chimica dei Sistemi Biologici 2025. Trieste 18-20 Giugno 2025. Book of abstracts (pp.68-68). Dettaglio

Romerio, A., Shaik, M., Italia, A., Lami, F., Galimberti, M., Peri, F. (2025). Developing New Toll-Like Receptor 4 (TLR4) Modulators As Innovative And Inexpensive Vaccine Adjuvants. Intervento presentato a: 3° Convegno Nazionale della Divisione di Chimica dei Sistemi Biologici - 18 - 20 Giugno 2025, Trieste, italy. Dettaglio

Italia, A., Romerio, A., Lami, F., Sarcinelli, G., Lenoci, M., Galli, M., et al. (2025). Functional impact of Toll-like Receptor 4 (TLR4) modulation in lung fibrosis-associated fibroblasts. Intervento presentato a: ABCD 2025. The Biennial Congress of the Italian Association of Cell Biology and Differentiation, Paestum, Italy. Dettaglio

Franco, A., Aladailleh, Z., Romerio, A., Italia, A., Lami, F., Shaik, M., et al. (2025). Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists. RSC MEDICINAL CHEMISTRY, 16(5), 2261-2269 [10.1039/D4MD00950A]. Dettaglio